West Paces Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
West Paces Advisors's ATRC Position: Q3 2026 in Review
West Paces Advisors held its AtriCure (ATRC) position steady in Q3 2026 at 25 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #611.
West Paces Advisors first reported a position in ATRC in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.98K in Q2 2021. 80 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- West Paces Advisors held 25 shares of AtriCure worth $1.4K as of Q3 2026.
- West Paces Advisors left its AtriCure share count unchanged in Q3 2026.
- AtriCure made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #611 holding.
- West Paces Advisors first reported a position in AtriCure in Q3 2020 and has held it in 21 quarters since.
- West Paces Advisors's AtriCure position peaked at $1.98K in Q2 2021.
- 80 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.